Bilirubin gesamt

Total Bilirubin (TBIL) is a blood biomarker that measures the total amount of bilirubin in the bloodstream, including both conjugated (direct) and unconjugated (indirect) forms. Bilirubin is a yellow compound that occurs in the normal catabolic pathway that breaks down heme in red blood cells. It is processed by the liver, where it is conjugated and excreted in bile. Clinically, TBIL is an important marker for assessing liver function and diagnosing liver diseases, such as hepatitis, cirrhosis, and bile duct obstruction. Elevated TBIL levels can indicate liver dysfunction, hemolysis, or bile duct obstruction, while low levels are less clinically significant. In the context of athletic performance, biohacking, or longevity, TBIL is not directly targeted, but maintaining liver health is crucial for overall metabolic function and detoxification processes. Researchers have found that liver function can be affected by factors such as exercise, diet, and supplementation, which indirectly influence TBIL levels. Caveats in measuring TBIL include potential confounders such as recent intense physical activity, fasting state, and certain medications that can interfere with bilirubin metabolism. Time-of-day variations are generally not significant, but consistent timing in testing can aid in comparability. Fasting is not typically required, but it may help standardize results. Understanding these factors is essential for accurate interpretation of TBIL levels in clinical and non-clinical settings.